Many glutamate-modulating drugs have been reported to have clinical efficacy in the treatment of obsessive-compulsive disorder (OCD). Here, Dr. Jeffrey Strawn discusses the role of the glutamatergic system in OCD.
Originally presented at the 2021 NEI Congress. To watch the full lecture, go to nei.global/encore
Learn about upcoming NEI Meetings: nei.global/mee...
Stay updated with email alerts: nei.global/upd...
Interested in Psychopharmacology? Check out the NEI Master Psychopharmacology Program: nei.global/mpp
Follow us on Facebook: nei.global/fac...
Follow us on LinkedIn: nei.global/lin...
Follow us on X: nei.global/twi...
Follow us on Instagram: nei.global/ins...
🎙 Listen to NEI Podcast: nei.global/pod...
Copyright © Neuroscience Education Institute. All rights reserved.
Негізгі бет Glutamatergic Interventions in OCD
Пікірлер: 6